GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...
Mike Ralston, CEO of Blencowe Resources (BRES) and Manuel Pablo Zúñiga-Pflücker, President and CEO of PetroTal (PTAL) will be presenting and taking live Q&A at focusIR's Investor Webinar on Tuesday ...
“By exploring pre-cancer biology and building on GSK’s expertise in the science ... to drive forward the research and development of new medicines.
(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...